Pharmaceutical excipients, which serve various therapeutic-enhancing purposes such as facilitating drug absorption or solubility, are now being recognized for their true importance by the pharmaceutical industry and by the world’s regulatory bodies, including the FDA and the European Medicines Agency. Factors shaping growth in this market include the development of novel innovations in response to the need for new excipients, and increased cooperation between major industry players. These forces as well as increases in global usage of pharmaceuticals will drive this market over the next five years.
BCC Research provides an in-depth analysis of the global markets for pharmaceutical excipients through its report Excipientsin Pharmaceuticals. According to the report, this market was valued at $5.9 billion in 2012 and is expected to reach $6.3 billion in 2013. BCC Research projects the market to grow to $8.8 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 6.9% from 2013 to 2018.
Use this report to:
As a market and technology summary, this report consolidates a wide range of industrial and technical information that will aid excipient suppliers, chemical companies, drug manufacturers, healthcare regulators, and congressional staffers who wish to keep current with today’s marketplace. The report will be of value to companies interested in entering or expanding their involvement in the field. The report also will provide senior marketing personnel and executive planners with insight about what materials can best satisfy customer demands. In addition, the market projections will be of interest to venture capitalists interested in exploring commercialization opportunities, as well as companies and personnel involved in designing and constructing chemical and excipient manufacturing plants and those who service such plants.
BCC Research provides an in-depth analysis of the global markets for pharmaceutical excipients through its report Excipientsin Pharmaceuticals. According to the report, this market was valued at $5.9 billion in 2012 and is expected to reach $6.3 billion in 2013. BCC Research projects the market to grow to $8.8 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 6.9% from 2013 to 2018.
Use this report to:
- Gain an overview of the global market for excipients in pharmaceuticals, including examinations of the effects of a crisis in the global supply chain, the demands of quality by design (QbD), and concerns about drug safety.
- Analyze global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Identify positive trends in the industry, including the development of innovative ideas in response to the need for new excipients and new levels of cooperation between major players.
- Evaluate coverage of the most important issues surrounding excipients: technological, regulatory, economic, and political.
- Evaluate excipient technology by chemical compounds, functional uses, delivery systems, and finished products.
- Review comprehensive company profiles of suppliers and other relevant industry participants.
As a market and technology summary, this report consolidates a wide range of industrial and technical information that will aid excipient suppliers, chemical companies, drug manufacturers, healthcare regulators, and congressional staffers who wish to keep current with today’s marketplace. The report will be of value to companies interested in entering or expanding their involvement in the field. The report also will provide senior marketing personnel and executive planners with insight about what materials can best satisfy customer demands. In addition, the market projections will be of interest to venture capitalists interested in exploring commercialization opportunities, as well as companies and personnel involved in designing and constructing chemical and excipient manufacturing plants and those who service such plants.
RSS Feeds – Pharmaceuticals
No comments:
Post a Comment